Scoop has an Ethical Paywall
Why are we paying more for an easy-open cap on medication?
Why are we paying more for an easy-open cap on medication?
GSK are being asked questions
related to the price of their two products that are marketed
primarily to ease arthritis pain. Both products, Voltaren
Osteo Gel and Voltaren Emugel, contain exactly the same
ingredients, but it appears consumers are paying an
additional $9.66 to have a cap that is easier to open for
those with arthritis.
“Many consumers, including those with arthritis, struggle with opening items and while consumers are prepared to pay a premium for accessibility, the $9.66 in our view is exorbitant” said Arthritis New Zealand CEO Sandra Kirby.
Accessible packaging is an ongoing issue for people with arthritis in New Zealand. Arthritis New Zealand commends GSK for recognising the issue. We encourage other companies to invest in accessible packaging as a good business practice, but urge them to be realistic about the additional costs”.
Accessible packaging is an ongoing issue for people with arthritis in New Zealand. Arthritis New Zealand is working with the Packaging Council of New Zealand to encourage other companies to invest in accessible packaging as a good business practice.
PATHA: Puberty Blocker Evidence Brief Affirms Aotearoa’s Approach
Tataki Auckland Unlimited: Into Ocean & Ice - Unveiling Antarctica's Past And Present
Health Coalition Aotearoa: Urgent Action Needed To Address Aotearoa’s Shameful Household Food Insecurity
GPNZ: 2023/24 New Zealand Health Survey - One Quarter Of Kiwi Adults Unable To Access General Practice
University of Auckland: Screentime Rules Reduce Childhood Obesity Risk
OraTaiao: Health Sector United In Opposition To The Treaty Principles Bill